The Serum Galactomannan Index Predicts Mortality in Hematopoietic Stem Cell Transplant Recipients With Invasive Aspergillosis

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Clinical Infectious Diseases (Impact Factor: 8.89). 06/2013; 57(7). DOI: 10.1093/cid/cit393
Source: PubMed


We examined the relationship between serum and bronchoalveolar lavage (BAL) galactomannan index (GMI) values and mortality
in allogeneic hematopoietic cell transplant recipients with invasive pulmonary aspergillosis. Using a clinical sign and symptom–initiated
approach, we found that the serum but not the BAL GMI level correlated with 42- and 180-day patient mortality.

Download full-text


Available from: Tobias M Hohl
Show more